Volume 10, Issue 1 Supplement, April 2015

In this issue (9 articles)

1. EditorialNotes

   Editorial

   Prof. Dr. med. Dieter Horstkotte Page 1

   Download PDF (231KB) View Article

2. OriginalPaper

   Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias

   Prof. Dr. med. P. Grützmacher, C. Kleinert… Pages 2-7

   Download PDF (365KB) View Article

3. OriginalPaper

   Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease

   Franz Heigl, Reinhard Hettich, Norbert Lotz… Pages 8-13

   Download PDF (461KB) View Article

4. OriginalPaper

   Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels

   Priv. Doz. Dr. med. Volker J. J. Schettler… Pages 14-20

   Download PDF (535KB) View Article

5. OriginalPaper

   Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects

   Prof. Gerd Schmitz MD, Evelyn Orsó Pages 21-25

   Download PDF (363KB) View Article

6. OriginalPaper

   Lipoprotein(a)—clinical aspects and future challenges

   Bilgen Kurt, Muhidien Soufi… Pages 26-32

   Download PDF (552KB) View Article

7. OriginalPaper

   Lipoprotein(a) – Einfluss auf die kardiovaskuläre Manifestation

   Dr. med. K.-P. Mellwig, C. Schatton… Pages 33-38

   Download PDF (414KB) View Article

8. OriginalPaper

   Extrakardiale Manifestation der Lipoprotein(a)-Erhöhung – Gehäuftes Auftreten von peripherer arterieller Verschlusskrankheit und Stenosen der Arteria carotis

   Dr. Frank van Buuren MBA… Pages 39-45

   Download PDF (385KB) View Article

9. OriginalPaper

   Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study

   Prof. Dr. Reinhard Klingel, Andreas Heibges… Pages 46-50

   Download PDF (546KB) View Article